420 with CNW — US DOJ Turmoil Unlikely to Derail Cannabis Rescheduling

The abrupt dismissal of Attorney General Pam Bondi by President Donald Trump is unlikely to significantly alter the trajectory of cannabis rescheduling efforts, according to several individuals familiar with the situation. 

Industry observers say the underlying dynamics remain unchanged, regardless of whether the Department of Justice is temporarily led by Todd Blanche or eventually by Lee Zeldin, who is widely viewed as the president’s preferred long-term appointee. 

Trump has repeatedly stated his intention to reclassify cannabis, and sources indicate that efforts within the DOJ are already progressing. One person close to the process suggested that movement could come within the next one to two months. 

Still, questions remain about what happens after a formal decision is made. Legal challenges are widely expected and could delay practical outcomes, including potential tax benefits for cannabis businesses. 

The industry has been waiting for further action since Trump signed an executive order on December 18 directing the DOJ to reclassify cannabis as a Schedule III substance under federal law. That move went further than steps taken under former President Joe Biden, whose administration concluded that marijuana has recognized medical use but left the process unfinished amid regulatory disputes. 

Trump’s stance is said to have been influenced in part by billionaire Howard Kessler, a longtime associate who has publicly credited CBD with helping him manage the effects of cancer treatment. 

Some industry leaders have responded positively to Blanche’s interim leadership. Jushi Holdings’ Trent Woloveck noted that Blanche has already been involved in discussions surrounding the proposed rule. That familiarity, he said, could help avoid delays tied to onboarding a new official. 

There are additional signs of momentum. According to federal records, Woloveck and a company lobbyist recently met with officials from the White House Office of Management and Budget (OMB), which oversees implementation of presidential directives. While no specific timeline was shared, the general sentiment within the industry suggests that rescheduling is increasingly seen as inevitable. 

Another development fueling that sentiment is the launch of a pilot program by the Center for Medicare and Medicaid Services (CMMS) to cover certain CBD treatments. The initiative allows accountable care organizations to apply for participation. At least five have already done so, according to a CMMS statement. 

While supporters view the program as a meaningful step forward, opposition remains active. Groups against cannabis reform filed a lawsuit challenging the CBD program, arguing that it failed to follow proper legal procedures. The groups have indicated they will pursue similar legal action if marijuana is formally rescheduled. 

Despite the anticipated pushback, sources say officials within the DOJ are well aware of the legal risks and are preparing for them as the process moves ahead. Marijuana firms like TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) will be hoping that the rescheduling process is completed expeditiously so that the industry can adjust to that new regulatory framework. 

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Archives

Select A Month
  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • September 2016
  • August 2016
  • July 2016
  • Official NewsWire Relationships

    Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

    CannabisNewsWire Currently Accepts

    Bitcoin

    Bitcoin

    Bitcoin Cash

    Bitcoin Cash

    Doge Coin

    Dogecoin

    Ethereum

    Ethereum

    Litecoin

    Litecoin

    USD Coin

    USD Coin

    Contact us: 512.354.7000